Pallas vs Ro: GLP-1 Telehealth Compared

If you're evaluating GLP-1 telehealth platforms, Ro (Roman) is probably on your shortlist — they were one of the earliest large-scale telehealth brands and run a well-known weight-loss program called the Ro Body Program. Pallas Health is a newer, more focused alternative built around the same goal but with a meaningfully different structure: no separate membership fee, all-in pricing, a free companion app, and — as of 2026 — one of the few platforms that still offers compounded GLP-1s alongside the FDA-approved brands.

This is an honest comparison. We'll tell you plainly where Ro is the better fit, and where Pallas makes more sense. Pricing on both sides changes often; the figures here reflect each platform's published pricing as of August 2026, and you should confirm current numbers on both sites before signing up.

The three differences that matter most in 2026

A lot changed in the GLP-1 telehealth market this year. Three differences now define the Pallas-vs-Ro decision:

1. Pallas offers FDA-approved brands and clinician-personalized compounded; Ro is branded-only. Following the industry-wide shift after Novo Nordisk's and Eli Lilly's 2026 settlements, Ro moved to FDA-approved branded medications only (Wegovy®, Ozempic®, Zepbound®, the Wegovy® pill, and Foundayo™). Pallas dispenses those FDA-approved brands too and, when a clinician decides a brand isn't the right fit, a per-patient compounded preparation. That's not a downgrade — it's personalization a fixed-dose pen can't do: a titration step the brand doesn't manufacture, or a formulation adjusted for the individual patient when a clinician judges it appropriate. A branded-only platform can't offer that at all.
2. Ro charges a separate membership fee; Pallas does not. Ro Body membership is $39 for the first month, then $149/month — about $99/month prepaying 3 months, $89/month prepaying 6, or $74/month prepaying a year — and Ro is explicit that "the cost of medication is not included in the membership cost." With Pallas, there is no membership fee at all: one plan price includes the provider, check-ins, dose adjustments, unlimited messaging, and shipping, and the Pallas companion app (iOS and Android) is free.
3. Care is 100% online and usually asynchronous. In most states there's no scheduled video visit to book — you complete everything online and can message your provider directly through the portal anytime, day or night, about side effects, dose questions, or refills. The same portal lets you track orders, request refills, switch plans, manage billing, and cancel — all yourself.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

Where Pallas is different

Both tiers, with compounding as personalization — not a knockoff. This is the headline. Ro is now branded-only. Pallas dispenses FDA-approved Wegovy®, Ozempic®, Zepbound®, and Mounjaro®, and — when a clinician decides a brand isn't the right fit — compounded semaglutide or compounded tirzepatide weekly injections. The reason a clinician reaches for compounded isn't price; it's fit: a titration step the brand doesn't manufacture, or a per-patient formulation when a clinician judges it appropriate. A fixed-dose branded pen can't be tailored that way, and a branded-only platform can't offer it at all.

No membership fee. With Ro you pay the $149/month membership before you've paid for any medication. With Pallas, there's nothing to pay before the medication itself, and the compounded price already includes the provider visit, dose adjustments, messaging, and shipping. What you see is what you pay.

All-in pricing, one number. Compounded semaglutide injection is $139 first month, then $597 every 12 weeks ($199/mo average), charged once a clinician prescribes. Cancel anytime. Compounded tirzepatide injection is $179 first month, then $897 every 12 weeks ($299/mo average), charged once a clinician prescribes. Cancel anytime. The price stays the same as your dose titrates up — no intro-rate surprises beyond what's stated up front, no separate membership line, no add-ons.

A free companion app. The Pallas companion app (Protein & GLP-1 Tracker, on iOS and Android) tracks protein, steps, weight trend, and dose reminders. It's free, with no separate subscription — useful whether or not you're a prescription patient.

Everything self-serve in a 100%-online portal. In most states, care is fully asynchronous — no video visit to schedule. Check your order status and shipment, request a refill, switch your plan, update billing, and cancel anytime — without calling anyone. The piece patients value most: message your provider directly through the portal anytime, day or night, about a side effect, a dose question, or a refill, and they respond, usually within a business day.

Where Ro is the stronger choice

We're not going to pretend Ro has no advantages. It has several real ones:

The longer track record. Ro has operated since 2017 and treated millions of patients across its broader platform. If brand longevity and scale reassure you, that's legitimate.

Insurance help on branded medications. Ro runs an insurance concierge that works to get your branded GLP-1 covered — including a free coverage checker and prior-authorization help — which, if your plan covers weight-loss GLP-1s, can bring your medication cost down to a copay. Pallas is cash-pay and does not route insurance today. For an insured patient who wants brand-name Wegovy® or Zepbound®, this can make Ro meaningfully cheaper than Pallas's cash-pay brand pricing. We'll say that plainly.

Branded cash-pay sticker prices. Through manufacturer partnerships, Ro's branded prices are low — as of August 2026, the Wegovy® pen starts around $199/month at the starting dose (rising to $349–399 at higher doses), the Wegovy® pill from $149, and Zepbound® from $299. These are below Pallas's cash-pay brand-name prices. If your heart is set on a specific FDA-approved brand and you're paying cash, compare the brand sticker directly — and remember to add Ro's membership to the total.

Structured coaching. Ro leans into habit coaching and a "Body Program" framing. Some patients want that structure; Pallas is deliberately more medication-first.

The pricing breakdown, honestly

The comparison depends entirely on which medication you want — and this is where the membership fee changes the math.

If you want a compounded GLP-1

There's no contest, because Ro no longer offers one. Pallas's compounded plans are all-in:

• Pallas semaglutide injection: $139 first month, then $597 every 12 weeks ($199/mo average), charged once a clinician prescribes. Cancel anytime. Provider care, dose adjustments, messaging, and shipping included — and no $149 membership stacked on top.
• Pallas tirzepatide injection: $179 first month, then $897 every 12 weeks ($299/mo average), charged once a clinician prescribes. Cancel anytime. Same all-in structure.

If a compounded preparation is what your clinician recommends, Pallas is the option that still has it.

If you want an FDA-approved brand and you're paying cash

Here the membership fee is the swing factor. With Ro, your true monthly cost is the $149 membership plus the medication (for example, roughly $199–399/month for the Wegovy® pen depending on dose). That's roughly $350–550/month all-in, and about $1,788/year in membership alone at the monthly rate before a single dose.

With Pallas there's no membership — but our brand-name medications are cash-pay at list-style pricing, which runs higher per dose than Ro's partnership pricing. So:

• Cost-conscious, insured, wants brand: Ro's insurance concierge can win on net cost.
• Wants brand, no coverage, hates recurring fees: run the all-in numbers both ways — Ro's $149/month membership adds up fast.
• Wants compounded or all-in simplicity: Pallas.

The honest summary: Pallas wins decisively on the membership-fee question, on all-in transparency, and on still offering compounded. Ro can win on net cost for an insured patient who wants a specific FDA-approved brand, thanks to its insurance concierge and manufacturer pricing.

Product experience differences

Managing your care

This is a clearer win for Pallas than it used to be. Care is 100% online — asynchronous in most states, so there's no video visit to schedule — and the patient portal lets you do essentially everything yourself: see your order status and tracking, request refills, switch between plans, update payment and billing, and cancel — all without a phone call. The piece patients lean on most is direct provider messaging: send a note anytime, day or night, about a side effect, a dose question, or a refill, and your provider replies, usually within a business day. Ro offers account management and messaging too; the difference is how much Pallas pushes toward fully self-serve.

How they frame weight loss

Ro positions its program as a broad "Body Program" with lifestyle and accountability layers. Pallas takes a more direct approach — here's the medication, here's a licensed provider who adjusts dosing, here's unlimited messaging when you need it, plus a free companion app if you want to track protein and steps. Less curriculum, more medication-first.

Intake and qualification

Both intakes are online, take about five minutes, and ask similar medical questions. Either qualifies you within about a business day. Pallas's intake is more clinical and to-the-point; Ro's carries more coaching copy.

Pharmacy and shipping

Both use US-licensed pharmacies and ship in discreet packaging; timelines are broadly similar (2–5 business days) and depend on routing and your state.

Who should choose which

Ro is probably the better fit if:

• You want a specific FDA-approved brand and you have insurance that may cover it (the insurance concierge is a real advantage)
• You value a structured coaching layer alongside the medication
• The longer operating track record matters to you
• You're comparing branded cash-pay sticker prices and want the lowest per-dose number

Pallas is probably the better fit if:

• You want a clinician's full toolkit — FDA-approved brands and the option of a personalized compounded preparation when a brand's fixed doses or formulation aren't the right fit (Ro no longer offers compounded)
• You don't want to pay a recurring membership fee on top of medication
• You prefer one flat, all-in price that stays the same as your dose changes
• You want care that's 100% online and asynchronous, with the ability to message your provider directly anytime about symptoms or refills
• You want to manage everything yourself — orders, refills, plan switches, billing — in one portal
• You'd use a free companion app (iOS and Android) to track protein, steps, and your weight trend

Either works well if:

• You want an FDA-approved brand, you're paying cash, and you've compared the all-in numbers (Pallas's no-membership pricing vs. Ro's membership + medication)

Switching between them

Both platforms support clean transitions. Bring your prescription history (export it from the patient portal), your current dose, and any recent lab work. A new provider picks up from where you are — no need to restart titration unless you've been off medication for more than four weeks. For the clinical side of switching molecules, see semaglutide vs tirzepatide.

References

Platform pricing and program details reflect each company's publicly published terms as of August 2026 and change frequently — confirm current numbers on each platform's site before enrolling. The regulatory basis for compounded preparations is summarized by the FDA.

1. Ro. Ro Body Program — membership and medication pricing, as published August 2026 ($39 first month, then $149/month; 3-, 6-, and 12-month prepay tiers; medication billed separately).
2. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.

Bottom line: Ro is branded-only now, charges a $149/month membership on top of medication, and shines for insured patients who want a specific FDA-approved brand. Pallas charges no membership and gives a clinician the full toolkit — FDA-approved brands plus a personalized compounded preparation when a brand's fixed doses or formulation aren't the right fit. Compounded pricing is one all-in number that stays flat at every dose, care is 100% online and async with anytime provider messaging, and you run everything — orders, refills, plan changes, billing — from one self-serve portal, plus a free companion app on iOS and Android. If you want fee-free all-in simplicity or a clinician who can personalize beyond a fixed-dose pen, Pallas is the better fit; if you want branded with insurance help, Ro is worth a look.